Clinical trials recruiting in Villeurbanne, France

Phase breakdown

Conditions recruiting in Villeurbanne, France

Recruiting trials in Villeurbanne, France

• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
  NCT05211895 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
  NCT07011745 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
  NCT06701513 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
  NCT06283966 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female)
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07169578 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female)
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
  NCT05511363 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
  NCT06976216 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female)
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
  NCT06937229 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female)
• Assessment of Informal Support Provided by Caregivers at Different Stages of Alzheimer's Disease
  NCT07409506 · Phase: Not specified · Ages: 60 Years and older · Sex: All (male and female)
• Better4All Personalized Intervention Pilot Study
  NCT07120802 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Biological Bank for Atrial Fibrillation and Stroke
  NCT03611816 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
  NCT07207811 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure
  NCT06427304 · Phase: Not specified · Ages: 80 Years and older · Sex: All (male and female)
• DESTINY Breast Respond HER2-(Ultra)Low Europe
  NCT05945732 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• DRIVing Simulator and People With NeuroCognitive Disorders
  NCT06320639 · Phase: Not specified · Ages: 50 Years to 95 Years · Sex: All (male and female)
• Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
  NCT06742333 · Phase: Phase 2 · Ages: 18 Years to 45 Years · Sex: All (male and female)
• Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR)
  NCT07083089 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female)
• Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease
  NCT05926011 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 85 Years · Sex: All (male and female)
• Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes
  NCT06600555 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female)
• French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
  NCT06837454 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• French Registry for Monitoring Pregnancies for Multiple Sclerosis
  NCT03900221 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Intradialytic Exercise With Blood Flow Restriction in Hemodialysis Patients
  NCT07269379 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 79 Years · Sex: All (male and female)
• Long-term Real-world Study of Dupilumab in COPD : Patient Characteristics, Safety and Patient-reported Outcomes
  NCT07380711 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
  NCT06207981 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
  NCT06677060 · Phase: Phase 3 · Ages: 40 Years and older · Sex: All (male and female)
• Predictive Factors of Autonomy Loss in Real-life Cohort
  NCT03894254 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• Predictive Signature of Benralizumab Response
  NCT04565483 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female)
• Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
  NCT00271180 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer
  NCT07124858 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female)
• REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
  NCT06557798 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
  NCT06750289 · Phase: Phase 3 · Ages: 12 Years to 75 Years · Sex: All (male and female)
• Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer
  NCT04794075 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: Female
• UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
  NCT06726720 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Validation of a Remediation Method for Memory Impairments Through Motor Encoding in Patients With Alzheimer's Disease
  NCT07632755 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Villeurbanne, France?

34 recruiting trials have at least one study site in Villeurbanne, France.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.